The time to address this crisis is long overdue. The lawsuits naming and shaming the architects of this deadly epidemic are making headlines, finally, but Doc Brown sums it up best, “If we don’t change the regulatory process for opioids, it will happen again.”Read More
In the wake of the June 25th decision by the Federal Drug Administration to approve a cannabis-based CBD-rich epilepsy medication from GW Pharma, a new lawsuit has been filed by a medical marijuana user against the federal government.
The plaintiff is essentially calling the FDA as her first witness and this has the federal government tiptoeing through a minefield of their own making.Read More
The FDA’s Center for Drug Evaluation and Research has approved the legal use of CBD for patients ages 2 and up who suffer from very specific conditions: Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), two severe forms of childhood-onset epilepsy. With so much public support in the US for cannabis legalization – not just CBD legalization – the time is right for a major overhaul.Read More